RC
Rishabh Chopda
About Rishabh Chopda
Data last updated:
Rishabh Chopda is a Director at Rishabh Laboratories Pvt Ltd (since 2005), Director at Regalis Life Sciences Private Limited (since 2019) and Director at Aspire Pharmaceuticals Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹45.29 Cr; the largest is Rishabh Laboratories Pvt Ltd at ₹44.75 Cr (FY 2025). Earlier, Rishabh Chopda was a Director at Infinito Cables Private Limited (from 2020) and Director at Healworth Life Sciences Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 May 2005 | 1994 | ₹44.75 Cr (FY 2025) | Active | |
| Director | 12 Oct 2019 | 2016 | ₹51.5 Lakh (FY 2025) | Active | |
| Director | 12 Nov 2020 | 2020 | ₹2.5 Lakh (FY 2025) | Active | |
| Director | 15 May 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Sep 2020 | 2020 | Strike Off | ||
| Director | 08 Jul 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rishabh Chopda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Chopda | 00903764 | Rishabh Laboratories Pvt Ltd , Regalis Life Sciences Private Limited and 2 more | Director |
| Komal Chand Chopda | 01049696 | Rishabh Laboratories Pvt Ltd , Regalis Life Sciences Private Limited | Managing Director |
| Pramod Devi Chopda | 00929075 | Rishabh Laboratories Pvt Ltd | Director |
| Navin Deshlahra | 01623171 | Aspire Pharmaceuticals Private Limited | Director |
| Usha Sharma | 10056482 | Aspire Pharmaceuticals Private Limited | Director |
| Yamini Nirmal Maheshwari | Aspire Pharmaceuticals Private Limited | Company Secretary | |
| Shashank Hiralal Shah | 00379300 | Vitalis Health Sciences Private Limited | Director |
| Tanay Shah | 08713708 | Vitalis Health Sciences Private Limited | Director |
| Yogendra Kumar Choudhary | 06948897 | Vitalis Health Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishabh Chopda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishabh Chopda
Rishabh Chopda currently holds 4 directorships: Rishabh Laboratories Pvt Ltd (Director, since 09 May 2005, revenue ₹44.75 Cr (FY 2025)); Regalis Life Sciences Private Limited (Director, since 12 Oct 2019, revenue ₹51.5 Lakh (FY 2025)); Aspire Pharmaceuticals Private Limited (Director, since 12 Nov 2020, revenue ₹2.5 Lakh (FY 2025)); Vitalis Health Sciences Private Limited (Director, since 15 May 2025).
Rishabh Chopda was first appointed on 09 May 2005 as Director at Rishabh Laboratories Pvt Ltd. The most recent appointment on record is 15 May 2025 at Vitalis Health Sciences Private Limited.
The 3 current companies of Rishabh Chopda that report revenue have a combined latest revenue of ₹45.29 Cr: Rishabh Laboratories Pvt Ltd ₹44.75 Cr (FY 2025); Regalis Life Sciences Private Limited ₹51.5 Lakh (FY 2025); Aspire Pharmaceuticals Private Limited ₹2.5 Lakh (FY 2025).
Rishabh Chopda held 2 earlier board appointments: Infinito Cables Private Limited (Director, from 10 Sep 2020); Healworth Life Sciences Private Limited (Director, from 08 Jul 2008).
The current boards of Rishabh Chopda's companies include Ashish Chopda (Rishabh Laboratories Pvt Ltd), Komal Chand Chopda (Rishabh Laboratories Pvt Ltd), Pramod Devi Chopda (Rishabh Laboratories Pvt Ltd), Navin Deshlahra (Aspire Pharmaceuticals Private Limited), Usha Sharma (Aspire Pharmaceuticals Private Limited), Yamini Nirmal Maheshwari (Aspire Pharmaceuticals Private Limited), among others.